Iovance Biotherapeutics (IOVA) P/E (2013 - 2026)
Iovance Biotherapeutics (IOVA) P/E from Jul 1, 2013 to Jul 21, 2026. The TTM Iovance Biotherapeutics (IOVA) P/E is -5.97. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Iovance Biotherapeutics (IOVA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.97 | +137.34% |
| 2025 | -2.51 | -57.12% |
| 2024 | -5.86 | +41.22% |
| 2023 | -4.15 | +60.90% |
| 2022 | -2.58 | -70.08% |
| 2021 | -8.63 | -65.71% |
| 2020 | -25.16 | +43.47% |
| 2019 | -17.54 | +145.23% |
| 2018 | -7.15 | +13.03% |
| 2017 | -6.33 | -25.83% |
| 2016 | -8.53 | -35.36% |
| 2015 | -13.20 | -28.67% |
| 2014 | -18.50 | +156.52% |
| 2013 | -7.21 | N/A |
Comparison Iovance Biotherapeutics (IOVA) P/E with competitors
Iovance Biotherapeutics (IOVA) P/E is -5.97.